- Home
- PGHL vs KMDA Comparison
PGHL vs KMDA Comparison
Compare PGHL & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGHL
- KMDA
- Stock Information
- Founded
- PGHL 2018
- KMDA 1990
- Country
- PGHL Hong Kong
- KMDA Israel
- Employees
- PGHL N/A
- KMDA N/A
- Industry
- PGHL
- KMDA Biotechnology: Pharmaceutical Preparations
- Sector
- PGHL
- KMDA Health Care
- Exchange
- PGHL NYSE
- KMDA Nasdaq
- Market Cap
- PGHL 294.2M
- KMDA 349.6M
- IPO Year
- PGHL 2024
- KMDA N/A
- Fundamental
- Price
- PGHL $1.19
- KMDA $5.89
- Analyst Decision
- PGHL
- KMDA Strong Buy
- Analyst Count
- PGHL 0
- KMDA 2
- Target Price
- PGHL N/A
- KMDA $14.50
- AVG Volume (30 Days)
- PGHL 7.2M
- KMDA 31.9K
- Earning Date
- PGHL 02-15-2025
- KMDA 11-13-2024
- Dividend Yield
- PGHL N/A
- KMDA N/A
- EPS Growth
- PGHL N/A
- KMDA 124.29
- EPS
- PGHL 0.05
- KMDA 0.27
- Revenue
- PGHL $13,464,430.00
- KMDA $158,380,000.00
- Revenue This Year
- PGHL N/A
- KMDA $15.38
- Revenue Next Year
- PGHL N/A
- KMDA $6.18
- P/E Ratio
- PGHL $24.54
- KMDA $21.95
- Revenue Growth
- PGHL 20.83
- KMDA 4.52
- 52 Week Low
- PGHL $1.03
- KMDA $4.74
- 52 Week High
- PGHL $107.36
- KMDA $6.53
- Technical
- Relative Strength Index (RSI)
- PGHL N/A
- KMDA 50.76
- Support Level
- PGHL N/A
- KMDA $5.75
- Resistance Level
- PGHL N/A
- KMDA $5.90
- Average True Range (ATR)
- PGHL 0.00
- KMDA 0.18
- MACD
- PGHL 0.00
- KMDA -0.03
- Stochastic Oscillator
- PGHL 0.00
- KMDA 35.00
About PGHL PRIMEGA GROUP HOLDINGS LIMITED
Primega Group Holdings Ltd is engaged in transportation services. It operates in the Hong Kong construction industry, mainly handling the transportation of materials excavated from construction sites. Its services principally comprise (i) soil and rock transportation services; (ii) diesel oil trading; and (iii) construction works, which mainly include ELS works and bored piling. The company provide services as a subcontractor to other construction contractors in Hong Kong. Maximum revenue is generated from soil and rock transportation services.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.